Recent developments on co-crystal polymorphs: from formation to prediction
Co-crystals offer a promising strategy to create drug constructs for which the pharmacokinetic properties of an active pharmaceutical ingredient can be improved without compromising its pharmacological effectiveness.
Authors
- Thomas Rades (ORCID: https://orcid.org/0000-0002-7521-6020)
- Philipp Hans (ORCID: https://orcid.org/0000-0002-3505-9884)
- Anders S. Larsen (ORCID: https://orcid.org/0000-0002-3445-9421)
- Inês C. B. Martins (ORCID: https://orcid.org/0000-0002-1639-7554)
- Yanbin Jiang (ORCID: https://orcid.org/0000-0001-8984-0302)
- Yunxia Li
- Di Xu (ORCID: https://orcid.org/0000-0003-3536-4173)
- Xiaoxiao Liang
Institutions
- University of Copenhagen (DK)
- Guangdong University of Petrochemical Technology (CN)
- South China University of Technology (CN)
Publication Details
- Journal
- CrystEngComm
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1039/d5ce00652j
- Citations
- 5
- Primary Topic
- Crystallization and Solubility Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.59